Saturday 17 October 2026
Export PRCT’s income statement to Excel — free account
PROCEPT BioRobotics Corporation
PRCT Healthcare Medical Devices
PROCEPT BioRobotics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $308.1 million, up 37.2% from fiscal 2024. In the quarter to June 2026, revenue grew 19.3%, EPS fell 34.3%, free cash flow fell 24.4% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
17.57
0.58
−3.20%
Follow PRCT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 5 | 4 | 4 |
| (27.22%) | (24.89%) | (27.81%) | (30.24%) | ||
| (19.10%) | (18.34%) | (20.36%) | (22.12%) | ||
ROIC |
(42.04%) | (49.56%) | (44.34%) | (43.57%) | |
Return on Tangible Assets |
(19.63%) | (23.03%) | (25.87%) | (28.29%) | |
Average Days of Receivables |
102.85 | 98.97 | 109.25 | 116.43 | |
Free Cash Flow per Share |
(1.43) | (1.05) | (1.43) | (1.49) | |
Free Cash Flow |
(79.73) | (58.34) | (80.57) | (84.92) | |
Capital Expenditures |
(8.68) | (9.36) | (10.43) | (10.58) | |
| Other line items | |||||
Cash ROIC |
(10.98%) | (8.29%) | (12.49%) | (13.70%) | |
Accounts Receivable Turnover |
3.91 | 3.69 | 3.67 | 3.58 | |
Accounts Payable Turnover |
8.11 | 8.19 | 6.89 | 8.99 | |
Inventory Turnover |
1.81 | 1.76 | 1.66 | 1.68 | |
Average Days of Payables |
38.17 | 56.42 | 59.31 | 45.57 | |
Days of Inventory on Hand |
229.03 | 230.74 | 243.95 | 233.04 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
22.44% | 23.14% | 23.71% | 23.36% | |
Selling, General and Administrative Expense of Revenue |
72.96% | 74.28% | 74.12% | 74.72% | |
Share Based Compensation of Revenue |
15.29% | 15.45% | 15.70% | 15.69% | |
Interest Coverage |
(25.28) | (28.96) | (30.91) | (32.88) | |
Operating CF/Net income |
0.84 | 0.51 | 0.68 | 0.68 | |
Depreciation/Fixed assets |
0.20 | 0.21 | 0.21 | 0.22 | |
Capex/Depreciation |
(1.42) | (1.46) | (1.57) | (1.50) | |
Revenue per Share |
5.38 | 5.55 | 5.70 | 5.91 | |
Operating CF per Share |
(1.27) | (0.88) | (1.24) | (1.30) | |
Capex per Share |
(0.16) | (0.17) | (0.18) | (0.19) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates